Harvard Medical School-ko ikertzaileekin lankidetzan egindako argitalpenak (78)

2022

  1. Determinants of effective treatment coverage for major depressive disorder in the WHO World Mental Health Surveys

    International Journal of Mental Health Systems, Vol. 16, Núm. 1

  2. Increased risks for mental disorders among LGB individuals: cross-national evidence from the World Mental Health Surveys

    Social Psychiatry and Psychiatric Epidemiology, Vol. 57, Núm. 11, pp. 2319-2332

  3. Patterns and correlates of patient-reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys

    World Psychiatry, Vol. 21, Núm. 2, pp. 272-286

  4. Perceived helpfulness of service sectors used for mental and substance use disorders: Findings from the WHO World Mental Health Surveys

    International Journal of Mental Health Systems, Vol. 16, Núm. 1

  5. Perceived helpfulness of treatment for social anxiety disorder: findings from the WHO World Mental Health Surveys

    Social Psychiatry and Psychiatric Epidemiology, Vol. 57, Núm. 10, pp. 2079-2095

  6. Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive Disorder

    Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 61, Núm. 4, pp. 495-507

  7. The associations between traumatic experiences and subsequent onset of a substance use disorder: Findings from the World Health Organization World Mental Health surveys

    Drug and Alcohol Dependence, Vol. 240

  8. Toward measuring effective treatment coverage: Critical bottlenecks in quality- and user-adjusted coverage for major depressive disorder

    Psychological Medicine, Vol. 52, Núm. 10, pp. 1948-1958

  9. Transdiagnostic development of internalizing psychopathology throughout the life course up to age 45: A World Mental Health Surveys report

    Psychological Medicine, Vol. 52, Núm. 11, pp. 2134-2143